Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Liver Cancer

7 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Diagnostic

    VICCGI14124

    03/13/2015

    PET Imaging of Hepatocellular Carcinoma with 18F-FSPG

    Other

    VICCGI1523

    07/01/2015

    Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Registry

    Treatment

    VICCMD15110

    04/05/2016

    A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

    Treatment

    VICCGIP1536

    10/26/2015

    A Phase 1 Study of Alisertib (MLN8237) in combination with mFOLFOX in Gastrointestinal Tumors

    Treatment

    VICCGI1586

    07/31/2015

    A Humanitarian Device Exemption Treatment Protocol of TheraSphere? for Treatment of Primary Liver Cancer

    Treatment

    CTSUGI80702-M

    05/05/2011

    A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or placebo for patients with Resected Stage III Colon Cancer

    Treatment

    CTSUGIC80802-M

    12/07/2010

    Phase III randomized study of sorafenib (IND 69896, NSC 724772) plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)


    Print this page for your doctor